Literature DB >> 9404383

Proteoglycans: the "Teflon" of the airways?

C P Page1.   

Abstract

Proteoglycans are a family of structurally distinct, polyanionic complex carbohydrates composed of repeating disaccharide units. Proteoglycans include heparin, heparan sulphate, chondroitin 4-sulphate, chondroitin 6-sulphate, dermatan sulphate, and hyaluronic acid. Heparin is found in the granules of a subset of mast cells where it is bound to various mediators including histamine. Heparan sulphate has a much wider distribution in the body, being associated with stromal matrices, basement membrane and many cell surfaces, particularly the surface of endothelial cells. Heparin is an anticoagulant, but it is now very apparent that it possesses many other biological activities that have relevance to our understanding of lung diseases, particularly inflammatory diseases of the airway. Recent evidence suggests in the airway when administered by inhalation that could be exploited therapeutically.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404383      PMCID: PMC1758436          DOI: 10.1136/thx.52.10.924

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

Review 1.  Immunomodulating activity of heparin.

Authors:  A Górski; M Wasik; M Nowaczyk; G Korczak-Kowalska
Journal:  FASEB J       Date:  1991-06       Impact factor: 5.191

2.  Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides.

Authors:  D O Willenborg; C R Parish
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

3.  Heparin-like anticoagulants in asthma.

Authors:  E C Lasser; R A Simon; S G Lyon; A E Hamblin; R Stein
Journal:  Allergy       Date:  1987-11       Impact factor: 13.146

4.  Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma.

Authors:  Z Diamant; M C Timmers; H van der Veen; C P Page; F J van der Meer; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

5.  Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with Dermatophagoides pteronyssinus allergen.

Authors:  W F Green; K Konnaris; A J Woolcock
Journal:  Am J Respir Cell Mol Biol       Date:  1993-05       Impact factor: 6.914

6.  The effect of inhaled heparin and related glycosaminoglycans on allergen-induced eosinophil infiltration in guinea-pigs.

Authors:  E A Seeds; A P Horne; D J Tyrrell; C P Page
Journal:  Pulm Pharmacol       Date:  1995 Apr-Jun

7.  Paradoxical response to heparin in 10 patients with ulcerative colitis.

Authors:  P R Gaffney; C T Doyle; A Gaffney; J Hogan; D P Hayes; P Annis
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

8.  Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects.

Authors:  S D Bowler; S M Smith; P S Lavercombe
Journal:  Am Rev Respir Dis       Date:  1993-01
  8 in total
  3 in total

Review 1.  New ideas on the pathophysiology and treatment of lung disease.

Authors:  D F Rogers; G J Laurent
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 2.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 3.  Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.

Authors:  Alba B Souza-Fernandes; Paolo Pelosi; Patricia R M Rocco
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.